CULLENFROST BANKERS INC
For the period ended Sep 30, 2024. Filed Oct 31, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2024 · Filed Oct 31, 2024
CFR$155.23-0.9%Stored close · as of Nov 6, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Changes in Shareholders’ Equity
| PreferredStock | CommonStock | AdditionalPaid-InCapital | RetainedEarnings | AccumulatedOtherComprehensiveIncome (Loss),Net of Tax | TreasuryStock | Total | |
|---|---|---|---|---|---|---|---|
| Three months ended: | |||||||
| Balance at beginning of period | $145,452 | $644 | $1,064,070 | $3,810,008 | $(1,309,344) | $(45,025) | $3,665,805 |
| Net income | — | — | — | 146,501 | — | — | 146,501 |
| Other comprehensive income (loss), net of tax | — | — | — | — | 393,911 | — | 393,911 |
| Stock option exercises/stock unit conversions (131,465 shares) | — | — | — | (4,124) | — | 14,399 | 10,275 |
| Stock-based compensation expense recognized in earnings | — | — | 1,759 | — | — | — | 1,759 |
| Purchase of treasury stock (188,889 shares) | — | — | — | — | — | (20,047) | (20,047) |
| Cash dividends – Series B preferred stock (approximately $11.13 per share which is equivalent to approximately $0.28 per depositary share) | — | — | — | (1,668) | — | — | (1,668) |
| Cash dividends – common stock ($0.95 per share) | — | — | — | (61,330) | — | — | (61,330) |
| Balance at end of period | $145,452 | $644 | $1,065,829 | $3,889,387 | $(915,433) | $(50,673) | $4,135,206 |
| Balance at beginning of period | $145,452 | $644 | $1,040,754 | $3,532,542 | $(1,305,027) | $(27,623) | $3,386,742 |
| Net income | — | — | — | 155,651 | — | — | 155,651 |
| Other comprehensive income (loss), net of tax | — | — | — | — | (473,800) | — | (473,800) |
| Stock option exercises/stock unit conversions (8,483 shares) | — | — | — | (217) | — | 813 | 596 |
| Stock-based compensation expense recognized in earnings | — | — | 3,111 | — | — | — | 3,111 |
| Purchase of treasury stock (111,956 shares) | — | — | — | — | — | (11,372) | (11,372) |
| Cash dividends – Series B preferred stock (approximately $11.13 per share which is equivalent to approximately $0.28 per depositary share) | — | — | — | (1,668) | — | — | (1,668) |
| Cash dividends – common stock ($0.92 per share) | — | — | — | (59,509) | — | — | (59,509) |
| Balance at end of period | $145,452 | $644 | $1,043,865 | $3,626,799 | $(1,778,827) | $(38,182) | $2,999,751 |
See accompanying Notes to Consolidated Financial Statements
Consolidated Statements of Changes in Shareholders’ Equity
| PreferredStock | CommonStock | AdditionalPaid-InCapital | RetainedEarnings | AccumulatedOtherComprehensiveIncome (Loss),Net of Tax | TreasuryStock | Total | |
|---|---|---|---|---|---|---|---|
| Nine months ended: | |||||||
| Balance at beginning of period | $145,452 | $644 | $1,055,809 | $3,657,688 | $(1,119,219) | $(23,927) | $3,716,447 |
| Net income | — | — | — | 427,690 | — | — | 427,690 |
| Other comprehensive income (loss), net of tax | — | — | — | — | 203,786 | — | 203,786 |
| Stock option exercises/stock unit conversions (254,093 shares) | — | — | — | (10,043) | — | 25,527 | 15,484 |
| Stock-based compensation expense recognized in earnings | — | — | 10,020 | — | — | — | 10,020 |
| Purchase of treasury stock (508,176 shares) | — | — | — | — | — | (52,273) | (52,273) |
| Cash dividends – Series B preferred stock (approximately $33.38 per share which is equivalent to approximately $0.83 per depositary share) | — | — | — | (5,006) | — | — | (5,006) |
| Cash dividends – common stock ($2.79 per share) | — | — | — | (180,942) | — | — | (180,942) |
| Balance at end of period | $145,452 | $644 | $1,065,829 | $3,889,387 | $(915,433) | $(50,673) | $4,135,206 |
| Balance at beginning of period | $145,452 | $643 | $1,029,756 | $3,309,671 | $(1,348,294) | $— | $3,137,228 |
| Net income | — | — | — | 495,422 | — | — | 495,422 |
| Other comprehensive income (loss), net of tax | — | — | — | — | (430,533) | — | (430,533) |
| Stock option exercises/stock unit conversions (72,496 shares) | — | 1 | 1,463 | (736) | — | 2,314 | 3,042 |
| Stock-based compensation expense recognized in earnings | — | — | 12,646 | — | — | — | 12,646 |
| Purchase of treasury stock (410,288 shares) | — | — | — | — | — | (40,496) | (40,496) |
| Cash dividends – Series B preferred stock (approximately $33.38 per share which is equivalent to approximately $0.83 per depositary share) | — | — | — | (5,006) | — | — | (5,006) |
| Cash dividends – common stock ($2.66 per share) | — | — | — | (172,552) | — | — | (172,552) |
| Balance at end of period | $145,452 | $644 | $1,043,865 | $3,626,799 | $(1,778,827) | $(38,182) | $2,999,751 |
See accompanying Notes to Consolidated Financial Statements
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.